Status:
COMPLETED
Assessment of Attentional Functioning in Children With HIV-1 Infection
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Attention Deficit Disorder With Hyperactivity
HIV Infections
Eligibility:
All Genders
Brief Summary
Children with symptomatic HIV-1 (Human Immunodeficiency Virus) infection are at increased risk for developing severely disabling neurological and neuropsychological deficits. HIV-1 related CNS (Centra...
Detailed Description
Children with symptomatic HIV-1 (Human Immunodeficiency Virus) infection are at increased risk for developing severely disabling neurological and neuropsychological deficits. HIV-1 related CNS (Centra...
Eligibility Criteria
Children and adolescents with HIV infection ages 5-18.
Have to be on another treatment protocol at the Division of Clinical Sciences, NCI.
No children with non-HIV associated CNS compromise, such as for example resulting from head trauma, or genetic factors.
No children with uncorrectable (20/20) vision.
Key Trial Info
Start Date :
December 1 1995
Trial Type :
OBSERVATIONAL
End Date :
October 1 2000
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00001497
Start Date
December 1 1995
End Date
October 1 2000
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI)
Bethesda, Maryland, United States, 20892